Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 60878-60879 [2013-24063]
Download as PDF
<![CDATA[
60878
Federal Register / Vol. 78, No. 191 / Wednesday, October 2, 2013 / Notices
For Further Information Contact: Felicia
Betancourt, National Center for
Immunization and Respiratory Diseases,
CDC, 1600 Clifton Road NE., MS–A27,
Atlanta, Georgia 30333, telephone 404/639–
8836; Email ACIP@CDC.GOV
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–24061 Filed 10–1–13; 8:45 am]
Officer, CDC, 4770 Buford Highway NE.,
Mailstop F–80, Atlanta, Georgia 30341,
Telephone: (770) 488–3585, Email:
EEO6@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Telephone: (770) 488–3585, Email:
EEO6@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–24062 Filed 10–1–13; 8:45 am]
BILLING CODE 4163–18–P
[FR Doc. 2013–24067 Filed 10–1–13; 8:45 am]
BILLING CODE 4160–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
tkelley on DSK3SPTVN1PROD with NOTICES
The meeting announced below
concerns Health Promotion and Disease
Prevention Research Centers, Funding
Opportunity Announcement (FOA)
DP14–001, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Times and Dates
8 a.m.–6:30 p.m., November 18, 2013
(Closed)
8 a.m.–6:30 p.m., November 19, 2013
(Closed)
8 a.m.–6:30 p.m., November 20, 2013
(Closed)
8 a.m.–6:30 p.m., November 21, 2013
(Closed)
Place: Centers for Disease Control and
Prevention, 1600 Clifton Road NE.,
Global Communications Center,
Auditorium B, Atlanta, Georgia 30333.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters To Be Discussed: The meeting
will include the initial review,
discussion, and evaluation of ‘‘Health
Promotion and Disease Prevention
Research Centers, FOA DP14–001’’.
For Further Information Contact: M.
Chris Langub, Ph.D., Scientific Review
VerDate Mar<15>2010
17:48 Oct 01, 2013
Jkt 232001
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Health Promotion and Disease
Prevention Research Centers, Funding
Opportunity Announcement (FOA)
DP14–001, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Times And Dates
8 a.m.–6:30 p.m., November 18, 2013
(Closed); 8 a.m.–6:30 p.m., November
19, 2013 (Closed); 8 a.m.–6:30 p.m.,
November 20, 2013 (Closed); 8 a.m.–
6:30 p.m., November 21, 2013 (Closed).
Place: Centers for Disease Control and
Prevention, 1600 Clifton Road NE.,
Global Communications Center,
Auditorium B, Atlanta, Georgia 30333.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters To Be Discussed: The meeting
will include the initial review,
discussion, and evaluation of ‘‘Health
Promotion and Disease Prevention
Research Centers, FOA DP14–001’’.
For Further Information Contact: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway NE.,
Mailstop F–80, Atlanta, Georgia 30341,
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns National Center for
Construction Safety and Health
Research and Translation (U60, Request
for Application (RFA) OH13–001, initial
review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 8 a.m.–5 p.m.,
November 19, 2013 (Closed); 8 a.m.–5
p.m., November 20, 2013 (Closed); 8
a.m.–12 p.m., November 21, 2013
(Closed).
Place: Embassy Suites Alexandria
Hotel, 1900 Diagonal Road, Alexandria,
Virginia 22314, Telephone: (703)842–
7030.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters To Be Discussed: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘National Center for Construction Safety
and Health Research and Translation
(U60), RFA OH13–001.’’
For Further Information Contact:
George Bockosh, M.S., Scientific Review
Officer, CDC/NIOSH, 626 Cochrans Mill
Road, Mailstop P–05, Pittsburgh,
Pennsylvania 15236, Telephone: (412)
E:\FR\FM\02OCN1.SGM
02OCN1
Federal Register / Vol. 78, No. 191 / Wednesday, October 2, 2013 / Notices
386–6465 and Joan Karr, Ph.D.,
Scientific Review Officer, CDC/NIOSH,
1600 Clifton Road, Mailstop E–74,
Atlanta, Georgia 30333, Telephone:
(404) 498–2506.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office Centers for Disease Control and
Prevention.
[FR Doc. 2013–24063 Filed 10–1–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns National Center for
Construction Safety and Health
Research and Translation (U60, Request
for Application (RFA) OH13–001, initial
review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 8 a.m.–5 p.m.,
November 19, 2013 (Closed); 8 a.m.–5
p.m., November 20, 2013 (Closed); 8
a.m.–12 p.m., November 21, 2013
(Closed).
Place: Embassy Suites Alexandria
Hotel, 1900 Diagonal Road, Alexandria,
Virginia 22314, Telephone: (703) 842–
7030.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters To Be Discussed: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘National Center for Construction Safety
and Health Research and Translation
(U60), RFA OH13–001.’’
For Further Information Contact:
George Bockosh, M.S., Scientific Review
Officer, CDC/NIOSH, 626 Cochrans Mill
Road, Mailstop P–05, Pittsburgh,
Pennsylvania 15236, Telephone: (412)
386–6465 and Joan Karr, Ph.D.,
Scientific Review Officer, CDC/NIOSH,
1600 Clifton Road, Mailstop E–74,
Atlanta, Georgia 30333, Telephone:
(404) 498–2506.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
60879
Description: The Program Instruction,
prepared in response to the enactment
of the Childrens Justice Act (CJA), Title
II of Public Law 111–320, Child Abuse
Prevention and Treatment Act
Reauthorization of 2010, provides
direction to the States and Territories to
accomplish the purposes of assisting
States in developing, establishing and
operating programs designed to
improve: (1) The assessment and
investigation of suspected child abuse
and neglect cases, including cases of
suspected child sexual abuse and
exploitation, in a manner that limits
additional trauma to the child and the
child’s family; (2) the assessment and
investigation of cases of suspected child
abuse-related fatalities and suspected
child neglect-related fatalities; (3) the
investigation and prosecution of cases of
child abuse and neglect, including child
sexual abuse and exploitation; and (4)
the assessment and investigation of
cases involving children with
disabilities or serious health-related
problems who are suspected victims of
child abuse or neglect. This Program
Instruction contains information
collection requirements that are found
in Public Law 111–320 at Sections
107(b) and 107(d), and pursuant to
receiving a grant award. The
information being collected is required
by statute to be submitted pursuant to
receiving a grant award. The
information submitted will be used by
the agency to ensure compliance with
the statute; to monitor, evaluate and
measure grantee achievements in
addressing the investigation and
prosecution of child abuse and neglect;
and to report to Congress.
Respondents: State Governments.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–24066 Filed 10–1–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Proposed Projects
Title: ACF Program Instruction:
Children’s Justice Act.
OMB No.: 0970–0425.
ANNUAL BURDEN ESTIMATES
Number of
respondents
Number of
responses per
respondent
Average burden
hours per
response
Total burden
hours
Application & Annual Report ...........................................................
tkelley on DSK3SPTVN1PROD with NOTICES
Instrument
52
1
60
3,120
Estimated Total Annual Burden
Hours: 3,120.
In compliance with the requirements
of Section 506(c)(2)(A) of the Paperwork
Reduction Act of 1995, the
Administration for Children and
VerDate Mar<15>2010
17:48 Oct 01, 2013
Jkt 232001
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
to the Administration for Children and
Families, Office of Planning, Research
and Evaluation, 370 L’Enfant
Promenade SW., Washington, DC 20447,
Attn: ACF Reports Clearance Officer.
Email address: infocollection@
E:\FR\FM\02OCN1.SGM
02OCN1
]]>Agencies
[Federal Register Volume 78, Number 191 (Wednesday, October 2, 2013)]
[Notices]
[Pages 60878-60879]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-24063]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns National Center for
Construction Safety and Health Research and Translation (U60, Request
for Application (RFA) OH13-001, initial review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date: 8 a.m.-5 p.m., November 19, 2013 (Closed); 8 a.m.-5
p.m., November 20, 2013 (Closed); 8 a.m.-12 p.m., November 21, 2013
(Closed).
Place: Embassy Suites Alexandria Hotel, 1900 Diagonal Road,
Alexandria, Virginia 22314, Telephone: (703)842-7030.
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to ``National Center for Construction Safety and Health Research and
Translation (U60), RFA OH13-001.''
For Further Information Contact: George Bockosh, M.S., Scientific
Review Officer, CDC/NIOSH, 626 Cochrans Mill Road, Mailstop P-05,
Pittsburgh, Pennsylvania 15236, Telephone: (412)
[[Page 60879]]
386-6465 and Joan Karr, Ph.D., Scientific Review Officer, CDC/NIOSH,
1600 Clifton Road, Mailstop E-74, Atlanta, Georgia 30333, Telephone:
(404) 498-2506.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office Centers for Disease
Control and Prevention.
[FR Doc. 2013-24063 Filed 10-1-13; 8:45 am]
BILLING CODE 4163-18-P
